Dyslipidemia

Metadata

Coding system
SNOMED CT (UK Clinical Edition)
Coding system release
41.0.0
Organisation
OpenSAFELY
Codelist ID
opensafely/dyslipidemia
Version ID
60a16e5e
Number of codes included
93

Actions

Download CSV Download definition Clone this codelist

Versions

  1. 60a16e5e Published
    Created: 24 Nov 2025 at 14:46

About

Description

This codelist aims to identify patients who have dyslipidemia.

Methodology

Search Terms

  • Dyslipidemia
  • Hyperlipidemia
  • Hypertriglyceridaemia
  • Hypercholesterolaemia
  • Familial hypercholesterolemia
  • Familial hyperlipoproteinemia
  • Lipid disorder

Inclusion Criteria for Codes

Codes which when applied in clinical records are expected to indicate that a dyslipidemia exists (or would exist without treatment) at the time of coding in >95% cases.

References

Signed off by

  • Andrew Brown, (March 3, 2026)
  • Elizabeth Morris, (March 3, 2026)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
109041000119107 Complex dyslipidemia
111231000119109 Dyslipidemia with high density lipoprotein below reference range and triglyceride above reference range due to type 2 diabetes mellitus
1197489003 Familial chylomicronemia syndrome
1251362006 Diffuse plane xanthoma due to hyperlipidemia
1256066001 Xanthoma due to secondary hyperlipidemia
1256071008 Xanthoma due to primary hypertriglyceridemia
1256073006 Xanthoma due to primary combined hyperlipidemia
1256075004 Xanthoma due to primary hypercholesterolemia
1258977001 Xanthoma due to primary chylomicronemia
129589009 Endogenous hyperlipidemia
129590000 Exogenous hyperlipidemia
129591001 Mixed hypercholesterolemia and hypertriglyceridemia
13644009 Hypercholesterolemia
137931000119102 Hyperlipidemia due to type 2 diabetes mellitus
137941000119106 Hyperlipidemia due to type 1 diabetes mellitus
154740003 (Hypercholesterolaemia: [pure] or [familial]) or (xanthoma - congenital)
154742006 Mixed hyperlipidaemia
154743001 Hyperlipidaemia NOS
1571000119104 Mixed hyperlipidemia due to type 1 diabetes mellitus
15771000119109 Familial hyperalphalipoproteinemia
190772003 (Hypercholesterolaemia: [pure] or [familial]) or (Fredrickson type IIa lipidaemia) or (low density lipoproteinaemia)
190773008 Hyperbetalipoproteinemia
190774002 Hyperlipidemia, group A
190777009 Other specified pure hypercholesterolemia
190778004 Pure hypercholesterolemia NOS
190780005 (Mixed hyperlipidaemia) or (Fredrickson lipidaemia type: [IIb] or [III]) or (xanthoma tuberosum)
190782002 Hyperlipidemia NOS
191107008 [X]Other hyperlipidemia
199801000000107 Dyslipidaema
214021000000106 Hypertriglyceridaemia
238038003 Familial hyperlipoproteinemia
238040008 Familial combined hyperlipidemia
238076009 Primary hypercholesterolemia
238077000 Polygenic hypercholesterolemia
238078005 Familial hypercholesterolemia - homozygous
238079002 Familial hypercholesterolemia - heterozygous
238080004 Hyperalphalipoproteinemia
238082007 Secondary hypercholesterolemia
238083002 Primary hypertriglyceridemia
238084008 Very low density lipoprotinemia
238085009 Fredrickson type IV hyperlipoproteinemia
238086005 Fredrickson type I hyperlipoproteinemia
238087001 Secondary hypertriglyceridemia
238088006 Primary combined hyperlipidemia
238089003 Secondary combined hyperlipidemia
267432004 Pure hypercholesterolemia
267433009 Pure hyperglyceridemia
267434003 Mixed hyperlipidemia
267435002 Familial hyperchylomicronemia
267500001 (Hypercholesterolaemia: [pure] or [familial]) or (xanthoma - congenital)
299465007 Familial multiple lipoprotein-type hyperlipidemia
302870006 Hypertriglyceridemia
31654005 Familial hypercholesterolemia
34349009 Familial type 5 hyperlipoproteinemia
34528009 Familial hypertriglyceridemia
368551000119104 Dyslipidemia due to type 1 diabetes mellitus
368761000000100 Dyslipidaemia
370992007 Dyslipidemia
390441000000105 [X]Other hyperlipidaemia
397915002 Fredrickson type IIa hyperlipoproteinemia
398036000 Familial hypercholesterolemia
398796005 Familial type 3 hyperlipoproteinemia
402473001 Sporadic primary hypertriglyceridemia
402474007 Primary polygenic type IIb combined hyperlipidemia
402475008 Primary acquired chylomicronemia
402725005 Hyperlipidemia with lipid deposition in skin
402726006 Primary chylomicronemia
402727002 Secondary hyperlipidemia
402785008 Primary genetic hyperlipidemia
402786009 Chylomicronemia syndrome
402787000 Primary genetic mixed hyperlipidemia
403827000 Familial lipoprotein lipase deficiency with type I phenotype
403828005 Familial lipoprotein lipase deficiency with type V phenotype
403829002 Familial hypercholesterolemia due to heterozygous low density lipoprotein receptor mutation
403830007 Familial hypercholesterolemia due to homozygous low density lipoprotein receptor mutation
403831006 Familial hypercholesterolemia due to genetic defect of apolipoprotein B
42569002 Familial type 3 hyperlipoproteinemia
445261005 Posttransplant hyperlipidemia
48190005 Familial combined hyperlipidemia
518591000000104 Familial hypercholesterolaemia due to homozygous low density lipoprotein receptor mutation
518601000000105 Familial hypercholesterolaemia due to heterozygous low density lipoprotein receptor mutation
518631000000104 Familial hypercholesterolaemia due to genetic defect of apolipoprotein B-100
55822004 Hyperlipidemia
633291000000106 Other specified pure hypercholesterolemia
633301000000105 Pure hypercholesterolemia NOS
633311000000107 Hyperlipidemia NOS
701000119103 Mixed hyperlipidemia due to type 2 diabetes mellitus
761000119102 Dyslipidemia due to type 2 diabetes mellitus
767133009 Familial hypercholesterolemia co-occurrent and due to combined heterozygous low density lipoprotein receptor and low density lipoprotein receptor adaptor protein 1 mutations
773726000 Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency
778111000000106 Polygenic hypercholesterolaemia
778121000000100 Familial combined hyperlipidaemia
890601000000107 Hypercholesterolaemia

This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.

Familial hyperlipoproteinemia

Included 5 out of 6 matching concepts.

Show matching concepts
  • Familial combined hyperlipidemia (238040008)
  • Familial hypercholesterolemia (31654005)
  • Familial hyperlipoproteinemia (238038003)
  • Familial lipoprotein lipase deficiency (275598004)
  • Fredrickson type I hyperlipoproteinemia (238086005)
  • Hyperbetalipoproteinemia (190773008)

Hypercholesterolaemia

Included 33 out of 77 matching concepts.

Show matching concepts
  • (Hypercholesterolaemia: [pure] or [familial]) or (Fredrickson type IIa lipidaemia) or (low density lipoproteinaemia) (190772003)
  • (Hypercholesterolaemia: [pure] or [familial]) or (xanthoma - congenital) (267500001)
  • (Hypercholesterolaemia: [pure] or [familial]) or (xanthoma - congenital) (154740003)
  • Assessment for familial hypercholesterolaemia (1326181000000100)
  • Assessment using Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia (867231000000101)
  • Assessment using Simon Broome diagnostic criteria for familial hypercholesterolaemia (519851000000103)
  • Assessment using Simon Broome diagnostic criteria for familial hypercholesterolaemia (519861000000100)
  • Carrier of familial hypercholesterolemia (66481000119109)
  • Dietary surveillance in hypercholesterolaemia (804641000000101)
  • Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia (872521000000106)
  • Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia (872531000000108)
  • Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia score (872541000000104)
  • FH: Hypercholesterolaemia (137716009)
  • FH: Hypercholesterolaemia in first degree relative (185671000000101)
  • FH: Hypercholesterolaemia in first degree relative (189111000000104)
  • Familial defective apolipoprotein B-100 (238081000)
  • Familial hyperalphalipoproteinemia (15771000119109)
  • Familial hypercholesterolaemia comprehensive genetic test result (163841000237109)
  • Familial hypercholesterolaemia due to genetic defect of apolipoprotein B-100 (518631000000104)
  • Familial hypercholesterolaemia due to heterozygous low density lipoprotein receptor mutation (518601000000105)
  • Familial hypercholesterolaemia due to homozygous low density lipoprotein receptor mutation (518591000000104)
  • Familial hypercholesterolaemia targeted genetic test result (163851000237107)
  • Familial hypercholesterolemia (398036000)
  • Familial hypercholesterolemia (31654005)
  • Familial hypercholesterolemia - heterozygous (238079002)
  • Familial hypercholesterolemia - homozygous (238078005)
  • Familial hypercholesterolemia co-occurrent and due to combined heterozygous low density lipoprotein receptor and low density lipoprotein receptor adaptor protein 1 mutations (767133009)
  • Familial hypercholesterolemia comprehensive genetic test (925221000000106)
  • Familial hypercholesterolemia due to genetic defect of apolipoprotein B (403831006)
  • Familial hypercholesterolemia due to heterozygous low density lipoprotein receptor mutation (403829002)
  • Familial hypercholesterolemia due to homozygous low density lipoprotein receptor mutation (403830007)
  • Familial hypercholesterolemia targeted genetic test (925211000000100)
  • Familial type 3 hyperlipoproteinemia (398796005)
  • Family history of Fredrickson type IIa hyperlipoproteinemia (1264211006)
  • Family history of double heterozygous familial hypercholesterolemia (109271000119105)
  • Family history of familial hypercholesterolemia (443454007)
  • Family history of hypercholesterolemia in first degree relative (417072001)
  • Family history: Hypercholesterolemia (160314003)
  • Fredrickson type IIa hyperlipoproteinemia (397915002)
  • Genetic variant causing familial hypercholesterolaemia not detected (204931000237105)
  • Genetic variant of uncertain significance for familial hypercholesterolaemia detected (1669121000000107)
  • Heterozygous familial hypercholesterolemia suspected (698600006)
  • History of hypercholesterolemia (414416008)
  • History of secondary hypercholesterolaemia (1363961000000109)
  • Hyperalphalipoproteinemia (238080004)
  • Hypercholesterolaemia (890601000000107)
  • Hypercholesterolaemia food (328295003)
  • Hypercholesterolemia (13644009)
  • Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (773726000)
  • Hypercholesterolemia food (328566006)
  • Hypercholesterolemia well controlled (444059002)
  • Hyperlipidemia, group A (190774002)
  • Mixed hypercholesterolemia and hypertriglyceridemia (129591001)
  • No family history of hypercholesterolaemia (858671000000107)
  • Other specified pure hypercholesterolemia (190777009)
  • Other specified pure hypercholesterolemia (633291000000106)
  • Polygenic hypercholesterolaemia (778111000000106)
  • Polygenic hypercholesterolemia (238077000)
  • Possible familial hypercholesterolaemia (754201000000107)
  • Possible familial hypercholesterolaemia (754211000000109)
  • Possible familial hypercholesterolemia (473145005)
  • Possible heterozygous familial hypercholesterolaemia (513831000000107)
  • Primary hypercholesterolemia (238076009)
  • Probable familial hypercholesterolaemia (867261000000106)
  • Probable familial hypercholesterolaemia (867271000000104)
  • Pure hypercholesterolemia (267432004)
  • Pure hypercholesterolemia NOS (190778004)
  • Pure hypercholesterolemia NOS (633301000000105)
  • Referral for assessment for familial hypercholesterolaemia (1326191000000103)
  • Referral for assessment for familial hypercholesterolaemia declined (1365251000000103)
  • Secondary hypercholesterolemia (238082007)
  • Simon Broome diagnostic criteria for familial hypercholesterolaemia (149601000000102)
  • Simon Broome diagnostic criteria for familial hypercholesterolaemia result (149611000000100)
  • Transmembrane protein 199 congenital disorder of glycosylation (1208738002)
  • Xanthoma due to primary hypercholesterolemia (1256075004)
  • [V]Dietary surveillance and counseling (316426000)
  • [V]Dietary surveillance and counselling (441901000000108)

Hyperlipidaemia

Included 69 out of 107 matching concepts.

Show matching concepts
  • (Mixed hyperlipidaemia) or (Fredrickson lipidaemia type: [IIb] or [III]) or (xanthoma tuberosum) (190780005)
  • Carrier of familial combined hyperlipidemia (66461000119100)
  • Chemically induced hyperlipidemia (426161002)
  • Chylomicronemia syndrome (402786009)
  • Dietary education for hyperlipidemia (429072008)
  • Diffuse plane xanthoma due to hyperlipidemia (1251362006)
  • Disorders of lipid metabolism (& [Fredrickson types] or [hyperlipidaemia]) (267499005)
  • Disorders of lipid metabolism (& [Fredrickson types] or [hyperlipidaemia]) (154739000)
  • Endogenous hyperlipidemia (129589009)
  • Exogenous hyperlipidemia (129590000)
  • Familial apolipoprotein C-II deficiency (33513003)
  • Familial chylomicronemia syndrome (1197489003)
  • Familial combined hyperlipidaemia (778121000000100)
  • Familial combined hyperlipidemia (238040008)
  • Familial combined hyperlipidemia (48190005)
  • Familial defective apolipoprotein B-100 (238081000)
  • Familial hyperalphalipoproteinemia (15771000119109)
  • Familial hypercholesterolemia (398036000)
  • Familial hypercholesterolemia - heterozygous (238079002)
  • Familial hypercholesterolemia - homozygous (238078005)
  • Familial hypercholesterolemia co-occurrent and due to combined heterozygous low density lipoprotein receptor and low density lipoprotein receptor adaptor protein 1 mutations (767133009)
  • Familial hypercholesterolemia due to genetic defect of apolipoprotein B (403831006)
  • Familial hypercholesterolemia due to heterozygous low density lipoprotein receptor mutation (403829002)
  • Familial hypercholesterolemia due to homozygous low density lipoprotein receptor mutation (403830007)
  • Familial hyperchylomicronemia (267435002)
  • Familial hypertriglyceridemia (34528009)
  • Familial lipoprotein lipase deficiency (275598004)
  • Familial lipoprotein lipase deficiency with type I phenotype (403827000)
  • Familial lipoprotein lipase deficiency with type V phenotype (403828005)
  • Familial multiple lipoprotein-type hyperlipidemia (299465007)
  • Familial type 3 hyperlipoproteinemia (42569002)
  • Familial type 3 hyperlipoproteinemia (398796005)
  • Familial type 5 hyperlipoproteinemia (34349009)
  • Family history of Fredrickson type IIa hyperlipoproteinemia (1264211006)
  • Family history of combined hyperlipidemia (64111000119100)
  • Family history of double heterozygous familial hypercholesterolemia (109271000119105)
  • Family history of familial hypercholesterolemia (443454007)
  • Family history of hypercholesterolemia in first degree relative (417072001)
  • Family history of hyperlipidemia (725117008)
  • Family history: Hypercholesterolemia (160314003)
  • Family history: Triglyceride high (275939003)
  • Fredrickson type IIa hyperlipoproteinemia (397915002)
  • Fredrickson type IV hyperlipoproteinemia (238085009)
  • Hepatic lipase deficiency (720940008)
  • History of secondary hyperlipidaemia (1363981000000100)
  • Hyperalphalipoproteinemia (238080004)
  • Hypercholesterolemia (13644009)
  • Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (773726000)
  • Hyperlipidaemia NOS (154743001)
  • Hyperlipidaemia clinical management plan (121731000000101)
  • Hyperlipidaemia clinical management plan (116991000000100)
  • Hyperlipidaemia diet education (300211000000107)
  • Hyperlipidaemia risk assessment with New Zealand table (171195004)
  • Hyperlipidaemia risk assessment with New Zealand table (148410002)
  • Hyperlipidaemia screen (& [cholesterol]) (148408004)
  • Hyperlipidaemia screen (& [cholesterol]) (171193006)
  • Hyperlipidaemia screening test (1015881000000105)
  • Hyperlipidaemia screening test (144406009)
  • Hyperlipidaemia screening test (167168002)
  • Hyperlipidemia (55822004)
  • Hyperlipidemia NOS (633311000000107)
  • Hyperlipidemia NOS (190782002)
  • Hyperlipidemia caused by steroid (114831000119107)
  • Hyperlipidemia clinical management plan (412778000)
  • Hyperlipidemia clinical management plan (736285004)
  • Hyperlipidemia due to type 1 diabetes mellitus (137941000119106)
  • Hyperlipidemia due to type 2 diabetes mellitus (137931000119102)
  • Hyperlipidemia risk assessment with New Zealand table (314504001)
  • Hyperlipidemia screening (268552003)
  • Hyperlipidemia screening test (314079002)
  • Hyperlipidemia screening test declined (9471000175101)
  • Hyperlipidemia screening test not done (4511000175106)
  • Hyperlipidemia with lipid deposition in skin (402725005)
  • Hyperlipidemia, group A (190774002)
  • Hypertriglyceridemia (302870006)
  • Mixed hypercholesterolemia and hypertriglyceridemia (129591001)
  • Mixed hyperlipidaemia (154742006)
  • Mixed hyperlipidemia (267434003)
  • Mixed hyperlipidemia due to type 1 diabetes mellitus (1571000119104)
  • Mixed hyperlipidemia due to type 2 diabetes mellitus (701000119103)
  • Polygenic hypercholesterolemia (238077000)
  • Posttransplant hyperlipidemia (445261005)
  • Primary acquired chylomicronemia (402475008)
  • Primary chylomicronemia (402726006)
  • Primary combined hyperlipidemia (238088006)
  • Primary genetic hyperlipidemia (402785008)
  • Primary genetic mixed hyperlipidemia (402787000)
  • Primary hypercholesterolemia (238076009)
  • Primary hypertriglyceridemia (238083002)
  • Primary polygenic type IIb combined hyperlipidemia (402474007)
  • Pure hypercholesterolemia (267432004)
  • Pure hyperglyceridemia (267433009)
  • Secondary combined hyperlipidemia (238089003)
  • Secondary hypercholesterolemia (238082007)
  • Secondary hyperlipidemia (402727002)
  • Secondary hypertriglyceridemia (238087001)
  • Sporadic primary hypertriglyceridemia (402473001)
  • Transient infantile hypertriglyceridemia and hepatosteatosis (773649005)
  • Transmembrane protein 199 congenital disorder of glycosylation (1208738002)
  • Very low density lipoprotinemia (238084008)
  • Xanthoma due to primary chylomicronemia (1258977001)
  • Xanthoma due to primary combined hyperlipidemia (1256073006)
  • Xanthoma due to primary hypercholesterolemia (1256075004)
  • Xanthoma due to primary hypertriglyceridemia (1256071008)
  • Xanthoma due to secondary hyperlipidemia (1256066001)
  • [X]Other hyperlipidaemia (390441000000105)
  • [X]Other hyperlipidemia (191107008)

Hypertriglyceridaemia

Included 15 out of 18 matching concepts.

Show matching concepts
  • Familial hyperchylomicronemia (267435002)
  • Familial hypertriglyceridemia (34528009)
  • Familial lipoprotein lipase deficiency (275598004)
  • Familial lipoprotein lipase deficiency with type I phenotype (403827000)
  • Familial lipoprotein lipase deficiency with type V phenotype (403828005)
  • Familial type 5 hyperlipoproteinemia (34349009)
  • Family history: Triglyceride high (275939003)
  • Fredrickson type IV hyperlipoproteinemia (238085009)
  • Hypertriglyceridaemia (214021000000106)
  • Hypertriglyceridemia (302870006)
  • Mixed hypercholesterolemia and hypertriglyceridemia (129591001)
  • Primary hypertriglyceridemia (238083002)
  • Pure hyperglyceridemia (267433009)
  • Secondary hypertriglyceridemia (238087001)
  • Sporadic primary hypertriglyceridemia (402473001)
  • Transient infantile hypertriglyceridemia and hepatosteatosis (773649005)
  • Very low density lipoprotinemia (238084008)
  • Xanthoma due to primary hypertriglyceridemia (1256071008)

Lipid disorder

Included 0 out of 126 matching concepts.

Show matching concepts
  • 7 dehydrocholesterol (416094000)
  • 8-dehydrocholesterol (707186003)
  • Alpha sitosterol (33204004)
  • Apolipoprotein B (26821000)
  • Apolipoprotein B truncated variant (259418007)
  • Apolipoprotein B-100 (102722006)
  • Apolipoprotein B-150 (102723001)
  • Apolipoprotein B-48 (102724007)
  • Apolipoprotein B3500 low density lipoprotein (259419004)
  • Apolipoprotein C-II (102727000)
  • Apolipoprotein E isoform (259604007)
  • Apolipoprotein E2 (102731006)
  • Apolipoprotein E3 (115518001)
  • Apolipoprotein E4 (115519009)
  • Attends for lipid disorder monitoring (300981000000108)
  • Attends for lipid disorder monitoring (300991000000105)
  • Attends lipid disorder monitoring (300971000000106)
  • Beta sitosterol (88631009)
  • Carbon (14-C) triolein (42417005)
  • Cholestanol (102742002)
  • Cholesterol (84698008)
  • Cholesterol derivative (416724002)
  • Cholesterol ester (73427004)
  • Cholesterol in chylomicrons (712626002)
  • Cholesterol in high density lipoprotein subfraction 2 (707084003)
  • Cholesterol in high density lipoprotein subfraction 2a (707086001)
  • Cholesterol in high density lipoprotein subfraction 2b (707124003)
  • Cholesterol in high density lipoprotein subfraction 3 (707125002)
  • Cholesterol in high density lipoprotein subfraction 3a (707126001)
  • Cholesterol in high density lipoprotein subfraction 3b (707128000)
  • Cholesterol in high density lipoprotein subfraction 3c (707127005)
  • Cholesterol in intermediate density lipoprotein subfraction 1 (707091000)
  • Cholesterol in intermediate density lipoprotein subfraction 2 (707092007)
  • Cholesterol in lipoprotein a (707098006)
  • Cholesterol in low density lipoprotein pattern A (707093002)
  • Cholesterol in low density lipoprotein pattern BI (707094008)
  • Cholesterol in low density lipoprotein pattern BII (707095009)
  • Cholesterol in low density lipoprotein, acetylated (707096005)
  • Cholesterol in low density lipoprotein, narrow density (707097001)
  • Cholesterol in very low density lipoprotein subfraction 3 (707099003)
  • Cholesterol in very low density lipoprotein, acetylated (707100006)
  • Cholesterol in very low density lipoprotein, beta (707101005)
  • Cholesterol sulfate (116772004)
  • Cholesteryl benzoate (765345005)
  • Cholesteryl octanoate (261245005)
  • Dietary education for hyperlipidemia (429072008)
  • Dietary education for lipid disorder (429071001)
  • Digalloyl trioleate (73126000)
  • Glyceryl trierucate (414353001)
  • High density lipoprotein (9422000)
  • High density lipoprotein cholesterol (102737005)
  • High density lipoprotein nascent (259560009)
  • High density lipoprotein subfraction (301870008)
  • High density lipoprotein subfraction 1 (259558007)
  • High density lipoprotein triglyceride (259557002)
  • High density lipoprotein, sub-fraction II (115332003)
  • High density lipoprotein, sub-fraction III (115333008)
  • Intermediate density lipoprotein cholesterol (259569005)
  • Lipid disorder diet education (300201000000105)
  • Lipid disorder follow up assessment (473211005)
  • Lipid disorder follow-up assessment (759271000000103)
  • Lipid disorder follow-up assessment (759281000000101)
  • Lipid disorder initial assessment (473212003)
  • Lipid disorder initial assessment (759251000000107)
  • Lipid disorder initial assessment (759261000000105)
  • Lipid disorder monitoring (315598000)
  • Lipid disorder monitoring (170972002)
  • Lipid disorder monitoring (148196003)
  • Lipid disorder monitoring 1st letter (301191000000103)
  • Lipid disorder monitoring 1st letter (301181000000100)
  • Lipid disorder monitoring 2nd letter (301301000000107)
  • Lipid disorder monitoring 2nd letter (301341000000105)
  • Lipid disorder monitoring 2nd letter (301351000000108)
  • Lipid disorder monitoring 2nd letter (301311000000109)
  • Lipid disorder monitoring administration (390700005)
  • Lipid disorder monitoring administration (389966004)
  • Lipid disorder monitoring administration (390908008)
  • Lipid disorder monitoring administration (713841000000104)
  • Lipid disorder monitoring administration (302851000000108)
  • Lipid disorder monitoring declined (301111000000107)
  • Lipid disorder monitoring first letter (301171000000102)
  • Lipid disorder monitoring first letter (716001000000100)
  • Lipid disorder monitoring invitation (711471000000106)
  • Lipid disorder monitoring second letter (716751000000102)
  • Lipid disorder monitoring second letter (301291000000108)
  • Lipid disorder monitoring status (308061000000101)
  • Lipid disorder monitoring telephone invitation (301541000000100)
  • Lipid disorder monitoring telephone invitation (716741000000100)
  • Lipid disorder monitoring telephone invitation (301551000000102)
  • Lipid disorder monitoring telephone invitation (301561000000104)
  • Lipid disorder monitoring third letter (716731000000109)
  • Lipid disorder monitoring third letter (301331000000101)
  • Lipid disorder monitoring verbal invitation (716461000000106)
  • Lipid disorder monitoring verbal invitation (301441000000104)
  • Lipid disorder monitoring verbal invitation (301461000000103)
  • Lipid disorder monitoring verbal invitation (301451000000101)
  • Lipid disorder treatment changed (759211000000108)
  • Lipid disorder treatment changed (759221000000102)
  • Lipid disorder treatment started (759161000000103)
  • Lipid disorder treatment started (759151000000101)
  • Lipid disorder treatment stopped (759191000000109)
  • Lipid disorder treatment stopped (759201000000106)
  • Lipoprotein and neutral lipid disorder marker (259417002)
  • Long chain triglyceride (706916003)
  • Low density lipoprotein cholesterol (102739008)
  • Lysolecithin (54446009)
  • Medium chain triglyceride (395781005)
  • Non-esterified cholesterol (102741009)
  • Non-high density lipoprotein cholesterol (312260007)
  • Phosphatidylcholine-sterol acyltransferase (88557001)
  • Phytanic acid (87477008)
  • Phytanic acid alpha-hydroxylase (259425000)
  • Plasma membrane high affinity low density lipoprotein receptor (259426004)
  • Pre-beta high density lipoprotein (259559004)
  • Sitosterol (259427008)
  • Triacylglycerol (85600001)
  • Triglyceride in high density lipoprotein subfraction 2 (707122004)
  • Triglyceride in high density lipoprotein subfraction 3 (707123009)
  • Triheptanoin (926370002)
  • Triolein (262222001)
  • Tripalmitin (67686004)
  • Tristearin (301868004)
  • Very low density lipoprotein cholesterol (102740005)
  • Very low density lipoprotein triglyceride (259570006)
  • lipid disorder monitoring declined (301131000000104)
  • lipid disorder monitoring declined (301121000000101)

dyslipid

Included 7 out of 9 matching concepts.

Show matching concepts
  • Complex dyslipidemia (109041000119107)
  • Dyslipidaema (199801000000107)
  • Dyslipidaemia (368761000000100)
  • Dyslipidemia (370992007)
  • Dyslipidemia due to type 1 diabetes mellitus (368551000119104)
  • Dyslipidemia due to type 2 diabetes mellitus (761000119102)
  • Dyslipidemia medication review (473234001)
  • Dyslipidemia with high density lipoprotein below reference range and triglyceride above reference range due to type 2 diabetes mellitus (111231000119109)
  • Hepatic lipase deficiency (720940008)

familial hypercholesterolemia

Included 11 out of 20 matching concepts.

Show matching concepts
  • (Hypercholesterolaemia: [pure] or [familial]) or (Fredrickson type IIa lipidaemia) or (low density lipoproteinaemia) (190772003)
  • Carrier of familial hypercholesterolemia (66481000119109)
  • Familial hypercholesterolemia (398036000)
  • Familial hypercholesterolemia (31654005)
  • Familial hypercholesterolemia - heterozygous (238079002)
  • Familial hypercholesterolemia - homozygous (238078005)
  • Familial hypercholesterolemia co-occurrent and due to combined heterozygous low density lipoprotein receptor and low density lipoprotein receptor adaptor protein 1 mutations (767133009)
  • Familial hypercholesterolemia comprehensive genetic test (925221000000106)
  • Familial hypercholesterolemia due to genetic defect of apolipoprotein B (403831006)
  • Familial hypercholesterolemia due to heterozygous low density lipoprotein receptor mutation (403829002)
  • Familial hypercholesterolemia due to homozygous low density lipoprotein receptor mutation (403830007)
  • Familial hypercholesterolemia targeted genetic test (925211000000100)
  • Familial type 3 hyperlipoproteinemia (398796005)
  • Family history of Fredrickson type IIa hyperlipoproteinemia (1264211006)
  • Family history of double heterozygous familial hypercholesterolemia (109271000119105)
  • Family history of familial hypercholesterolemia (443454007)
  • Fredrickson type IIa hyperlipoproteinemia (397915002)
  • Heterozygous familial hypercholesterolemia suspected (698600006)
  • Possible familial hypercholesterolemia (473145005)
  • Possible heterozygous familial hypercholesterolaemia (513831000000107)